This is a request for Research Scientist Development Award (Level II). The purpose of applying for an RSDA is to allow for a change in the terms of Dr. Kellogg's present position from a major involvement in teaching to allow her full-time committment to research. The objectives of the proposal are to pursue to provocative findings that have been reported from her laboratory to date concerning the effect of psychotherapeutic drugs on the developing brain. Specifically, experiments are designed to probe mechanisms mediating the effect of developmental exposure to diazepam on the new approaches to bear on the problem, and the learning of these new techniques is part of Dr. Kellogg's plans for professional growth. Immunocytochemical analysis of the noradrenergic (NE) terminal distribution in the hypothalamus and of specific NE target cells will assist in determining whether subpopulations of NE projections and target cells are primarily affected. Dr. Kellogg will collaborate with Dr. Gloria Hoffmann in the Department of Neurobilogy and Anatomy in the execution of the experiments and in the learning of the techniques. Autoradiography of benzodiazepine binding will be carried out to determine the localization of binding in the hypothalamus during the critical exposure period and to correlate the binding with ingrowth of NE fibers to the region. The procedure for autoradiography is being developed with assistance from local investigators. As part of the plans for professional growth, however, Dr. Kellogg will spend time in Switzerland with Dr. Margaret Schlumpf who has conducted many studies on neuroreceptors in fetal brain. Other experiments are designed to determine possible molecular mechanisms that may have been influenced by the early exposure or mediate the effects; such as changes in calcium availability, the influence of adenylate cyclase systems and/or alterations in function of the benzodiazepine- GABA binding complex. To prepare for future directions, Dr. Kellogg plans to begin to develop molecular biologic approaches to analysis of the nervous system with assistance from Dr. Robert Angerer in the Department of Biology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Development Award - Research (K02)
Project #
1K02MH000651-01A1
Application #
3070041
Study Section
Research Scientist Development Review Committee (MHK)
Project Start
1987-07-01
Project End
1992-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Arts and Sciences
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Inglefield, J R; Schwarzkopf, S B; Kellogg, C K (1994) Alterations in behavioral responses to stressors following excitotoxin lesions of dorsomedial hypothalamic regions. Brain Res 633:151-61
Kellogg, C K; Inglefield, J R; Taylor, M K et al. (1993) Importance of hypothalamic function to stressor-induced responsiveness of the GABAA receptor in the cerebral cortex: a non-corticosterone influence. Brain Res 609:244-52
Bitran, D; Purdy, R H; Kellogg, C K (1993) Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 45:423-8
Kellogg, C K; Primus, R J; Bitran, D (1991) Sexually dimorphic influence of prenatal exposure to diazepam on behavioral responses to environmental challenge and on gamma-aminobutyric acid (GABA)-stimulated chloride uptake in the brain. J Pharmacol Exp Ther 256:259-65
Bitran, D; Primus, R J; Kellogg, C K (1991) Gestational exposure to diazepam increases sensitivity to convulsants that act at the GABA/benzodiazepine receptor complex. Eur J Pharmacol 196:223-31
Bitran, D; Hilvers, R J; Kellogg, C K (1991) Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561:157-61
Primus, R J; Kellogg, C K (1991) Experience influences environmental modulation of function at the benzodiazepine (BZD)/GABA receptor chloride channel complex. Brain Res 545:257-64
Bitran, D; Hilvers, R J; Kellogg, C K (1991) Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of gamma-aminobutyric acid-benzodiazepine receptor-mediated chloride ion transport. Behav Neurosci 105:653-62
Kellogg, C K; Sullivan, A T; Bitran, D et al. (1991) Modulation of noise-potentiated acoustic startle via the benzodiazepine--gamma-aminobutyric acid receptor complex. Behav Neurosci 105:640-6
Primus, R J; Kellogg, C K (1991) Gonadal status and pubertal age influence the responsiveness of the benzodiazepine/GABA receptor complex to environmental challenge in male rats. Brain Res 561:299-306

Showing the most recent 10 out of 13 publications